FOXP3 (in)stability and cancer immunotherapy.

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Regulatory T cells (Tregs) play a critical role in immune homeostasis and are implicated in inflammatory diseases, autoimmune disorders, and cancer.
• Forkhead box P3 (FOXP3) is a master transcription factor essential for Treg lineage commitment and function.
• Dysregulation of FOXP3 impacts Treg stability, potentially leading to loss of immune suppressive function and contributing to disease pathogenesis.

Purpose of the Study:

• To review the current understanding of FOXP3's role in Treg stability and function within the tumor microenvironment (TME).
• To explore the molecular mechanisms, including post-translational modifications (ubiquitination, methylation, acetylation), that regulate FOXP3 stability.
• To discuss the implications of targeting FOXP3 for cancer immunotherapy strategies.

Main Methods:

• This review synthesizes existing literature on FOXP3 regulation and its impact on Tregs in cancer.
• It examines the influence of various signaling pathways and regulatory proteins (e.g., mTORC2, NAC1, Blimp-1, DTX1, USP22) on FOXP3 stability.
• The review discusses the differential dependence of Treg subsets on FOXP3.

Main Results:

• FOXP3 stability is influenced by a complex network of signaling pathways and post-translational modifications.
• Specific proteins and pathways can either stabilize or destabilize FOXP3, affecting Treg function and numbers.
• Treg subsets exhibit varying degrees of reliance on FOXP3, suggesting diverse regulatory mechanisms.

Conclusions:

• FOXP3 is a key determinant of Treg identity and function, with its stability being tightly regulated within the TME.
• Targeting FOXP3 or its regulatory pathways presents a potential strategy for enhancing cancer immunotherapy efficacy.
• Understanding the nuances of FOXP3 regulation across different Treg subsets is crucial for developing effective therapeutic interventions.